Privia Health Group, Inc. (NASDAQ:PRVA) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET
Company Participants
Robert Borchert - Senior Vice President, Investor and Corporate Communications
Shawn Morris - Chief Executive Officer
David Mountcastle - Executive Vice President and Chief Financial Officer
Parth Mehrotra - President and Chief Operating Officer
Conference Call Participants
Joshua Raskin - Nephron Research LLC
Albert Rice - Credit Suisse AG
Lisa Gill - JPMorgan Chase & Co.
Adam Ron - Bank of America Merrill Lynch
Richard Close - Canaccord Genuity Group Inc.
Whit Mayo - SVB Securities
Gary Taylor - Cowen and Company, LLC
David Larsen - BTIG LLC
Taji Phillips - Jefferies
Sandy Draper - Guggenheim Securities, LLC
Jessica Tassan - Piper Sandler & Co.
Operator
Good day, and thank you for standing by. Welcome to the Privia Health Q2 2022 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator instructions] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Robert Borchert, SVP of Investor and Corporate Communications. Please go ahead.
Robert Borchert
Thank you, Kyle, and good morning, everyone. Joining me today are Shawn Morris, our Chief Executive Officer; Parth Mehrotra, President and Chief Operating Officer; and David Mountcastle, our Chief Financial Officer. This call is being webcast and can be accessed from the Investor Relations section of priviahealth.com. Today's press release highlighting our financial and operating performance and the slide presentation accompanying our formal remarks are posted on the Investor Relations pages of priviahealth.com.
Following our prepared comments, we will open the line for questions. And we ask that you please limit yourself to one question and one follow-up, so we can get through the full queue in a timely fashion.
The financial results reported today and in the press release are preliminary and are not final until our Form 10-Q for the quarter ended June 30, 2022, is filed with the Securities and Exchange Commission. Some of the statements we will make today are forward-looking in nature based on our current expectations and our view of our business as of August 11, 2022.
Such statements, including those related to our future financial and operating performance and future business plans and objectives, are subject to risks and uncertainties that may cause actual results to differ materially. As a result, these statements should be considered in conjunction with the cautionary statements in today's press release and the risk factors described in our Company's most recent SEC filings. Finally, we may refer to certain non-GAAP financial measures on the call, and reconciliations of these measures to comparable GAAP measures are included in our press release and the accompanying slide presentation posted on our website.